NO20054762L - Polymorphs of aripiprazole - Google Patents

Polymorphs of aripiprazole

Info

Publication number
NO20054762L
NO20054762L NO20054762A NO20054762A NO20054762L NO 20054762 L NO20054762 L NO 20054762L NO 20054762 A NO20054762 A NO 20054762A NO 20054762 A NO20054762 A NO 20054762A NO 20054762 L NO20054762 L NO 20054762L
Authority
NO
Norway
Prior art keywords
aripiprazole
polymorphs
compounds
preparation
disclosed
Prior art date
Application number
NO20054762A
Other languages
English (en)
Other versions
NO20054762D0 (no
Inventor
Braj Bhushan Lohray
Vidya Bhushan Lohray
Kaushik Sata
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of NO20054762D0 publication Critical patent/NO20054762D0/no
Publication of NO20054762L publication Critical patent/NO20054762L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives nye polymorfer av aripiprazol, deres fremstilling, samt farmasøytiske preparater inneholdende forbindelsene og deres anvendelse.
NO20054762A 2003-04-25 2005-10-17 Polymorphs of aripiprazole NO20054762L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN412MU2003 2003-04-25
IN583MU2003 2003-06-06
PCT/IN2004/000113 WO2004106322A2 (en) 2003-04-25 2004-04-22 Polymorphs of aripiprazole

Publications (2)

Publication Number Publication Date
NO20054762D0 NO20054762D0 (no) 2005-10-17
NO20054762L true NO20054762L (no) 2006-01-24

Family

ID=33492303

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054762A NO20054762L (no) 2003-04-25 2005-10-17 Polymorphs of aripiprazole

Country Status (4)

Country Link
US (1) US20060270683A1 (no)
EP (1) EP1618103A2 (no)
NO (1) NO20054762L (no)
WO (1) WO2004106322A2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7714129B2 (en) 2003-12-16 2010-05-11 Teva Pharmaceutical Industries Ltd. Methods of preparing anhydrous aripiprazole form II
WO2005058835A2 (en) * 2003-12-16 2005-06-30 Teva Pharmaceutical Industries Ltd. Methods of preparing aripiprazole crystalline forms
DE202005020551U1 (de) 2004-02-05 2006-07-06 Teva Pharmaceutical Industries Ltd. 7-(4-Brombutoxy)-3,4-dihydrocarbostyril
US7507823B2 (en) 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
WO2006053781A1 (en) * 2004-11-18 2006-05-26 Synthon B.V. Process of making crystalline aripiprazole
SI1844036T1 (sl) * 2005-01-27 2015-12-31 Sandoz Ag Postopek za pripravo aripiprazola
EP1686126A1 (en) * 2005-01-27 2006-08-02 Sandoz AG Salts of aripiprazole
EP2783688A1 (en) * 2005-03-17 2014-10-01 Synhton B.V. Pharmaceutical tablets of crystalline type ii aripiprazole
CA2600541C (en) * 2005-03-17 2018-01-09 Synthon B.V. Process of making crystalline type ii aripiprazole
CA2605128A1 (en) * 2005-04-15 2007-01-11 Medichem, S.A. Syntheses and preparations of polymorphs of crystalline aripiprazole
HUP0500683A3 (en) * 2005-07-14 2009-03-30 Egis Gyogyszergyar Nyilvanosan New arylpiprazole salts for producing pharmaceutical composition
JP2008537540A (ja) * 2005-12-22 2008-09-18 テバ ファーマシューティカル インダストリーズ リミティド アリピプラゾールの粒径を小さくする方法
CA2627695A1 (en) * 2006-01-05 2007-07-19 Teva Pharmaceutical Industries Ltd. Dry formulations of aripiprazole
CN101351192A (zh) * 2006-01-05 2009-01-21 特瓦制药工业有限公司 阿立哌唑的湿法制粒的药用组合物
EP1880714A1 (en) 2006-07-20 2008-01-23 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof
US7799790B2 (en) 2006-07-20 2010-09-21 Helm Ag Amorphous aripiprazole and process for the preparation thereof
WO2008020453A2 (en) * 2006-08-17 2008-02-21 Unichem Laboratories Limited A process for the preparation of a novel crystalline polymorph of aripiprazole
ES2353444T3 (es) 2008-01-23 2011-03-02 Helm Ag Aripiprazol amorfo y procedimiento para su preparación.
EP2238976B1 (en) 2009-04-03 2012-06-27 Hexal AG Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
US9156822B2 (en) 2010-07-02 2015-10-13 The University Of North Carolina At Chapel Hill Functionally selective ligands of dopamine D2 receptors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
AR033485A1 (es) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma

Also Published As

Publication number Publication date
WO2004106322A3 (en) 2005-04-21
WO2004106322A2 (en) 2004-12-09
EP1618103A2 (en) 2006-01-25
NO20054762D0 (no) 2005-10-17
US20060270683A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
NO20054762L (no) Polymorphs of aripiprazole
IL175512A0 (en) Methods of preparing aripiprazole crystalline forms
SE0301372D0 (sv) Novel compounds
NO20093060L (no) Spirosykliske sykloheksanderivater
SE0101675D0 (sv) Novel composition
SE0301700D0 (sv) Novel compounds
NO20054083L (no) Nye sammenkoblede triazoloner og deres anvendelse
NO2014009I2 (no) Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser
NO20091299L (no) Substituerte sulfonamidderivater
NO20054032D0 (no) Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene.
SE0302811D0 (sv) Novel compounds
NO20085373L (no) P38 inhibitorer, deres fremstilling og anvendelse
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20052493D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
WO2004089947A3 (de) Neue verbindungen mit antibakterieller aktivität
NO20044261L (no) Indazoler substituerte med en anticanceros aktivitet
SE0301653D0 (sv) Novel compounds
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
SE0302546D0 (sv) New compounds
DK1511489T3 (da) Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
DE602004031410D1 (de) Inden derivate als pharmazeutika
NO20063293L (no) Farmasoytiske forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application